 LifeSci Acquisition Corp. LSACU, a blank check company targeting the biopharma, medical technology, digital health and healthcare services sectors, announced today that it priced its initial public offering of 6,000,000 units at 10.00 per unit. The units will begin trading on March 6, 2020, on the NASDAQ Capital Market NASDAQ under the symbol LSACU. Each unit consists of one share of common stock and one redeemable warrant, with each warrant entitling the holder to purchase one-half of one share of common stock at a price of 11.50 per whole share. 